Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(4-morpholinylcarbonyl)- - Names and Identifiers
Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(4-morpholinylcarbonyl)- - Physico-chemical Properties
Molecular Formula | C11H17NO4
|
Molar Mass | 227.26 |
Density | 1.264±0.06 g/cm3(Predicted) |
Boling Point | 425.0±45.0 °C(Predicted) |
pKa | 4.57±0.33(Predicted) |
Storage Condition | Room Temprature |
Sensitive | Irritant |
MDL | MFCD12027545 |
Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(4-morpholinylcarbonyl)- - Risk and Safety
Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(4-morpholinylcarbonyl)- - Introduction
2,2-Dimethyl-3-(morpholin-4-ylcarbonyl)-cyclopropanecarboxylic acid is an organic compound with the chemical formula C12H19NO4. It is a white solid, soluble in some organic solvents such as ethanol and dichloromethane.
This compound has several applications in the medical field. It is often used as an antimycotic, especially to inhibit the growth and reproduction of fungi. In addition, it is also being studied for the treatment of certain causes of diseases associated with fungal infections. However, the specific application and efficacy require further research and validation.
There are various methods of preparing 2,2-Dimethyl-3-(morpholin-4-ylcarbonyl)-cyclopropanecarboxylic acid. A common method is the reaction of 2,2-dimethyl-3-bromopropionic acid and N-morpholinone acid chloride in acetonitrile. The reaction is usually carried out at low temperature, and the product is purified by crystallization after the end of the reaction.
For safety information, there are limited toxicity data for 2,2-Dimethyl-3-(morpholin-4-ylcarbonyl)-cyclopropanecarboxylic acid. Depending on its structure and the toxicity profile of similar compounds, it may be irritating to the eyes, respiratory system and skin. During operation and use, it is recommended to take appropriate safety measures, such as wearing personal protective equipment (such as gloves, goggles and respiratory protection equipment) for protection. In case of accidental administration or contact, seek medical attention immediately and provide the compound's safety data sheet.
Last Update:2024-04-09 20:52:54